Pacifica Partners Inc. Novartis Ag Transaction History

Pacifica Partners Inc.

  • $235 Million
  • Q3 2024

A detailed history of Pacifica Partners Inc. transactions in Novartis Ag stock. As of the latest transaction made, Pacifica Partners Inc. holds 2,441 shares of NVS stock, worth $240,316. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,441
Previous 2,441 -0.0%
Holding current value
$240,316
Previous $259,000 8.11%
% of portfolio
0.12%
Previous 0.12%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 05, 2024
SELL
$92.27 - $101.54 $71,047 - $78,185
-770 Reduced 23.98%
2,441 $246,000
Q4 2022

Jan 11, 2023
BUY
$75.55 - $92.52 $29,691 - $36,360
393 Added 13.95%
3,211 $293,000
Q2 2022

Jul 22, 2022
SELL
$80.52 - $93.75 $2,496 - $2,906
-31 Reduced 1.09%
2,818 $241,000
Q3 2021

Oct 07, 2021
SELL
$81.78 - $95.14 $1,472 - $1,712
-18 Reduced 0.63%
2,849 $236,000
Q2 2021

Jul 14, 2021
BUY
$85.24 - $94.15 $2,642 - $2,918
31 Added 1.09%
2,867 $261,000
Q1 2021

Apr 08, 2021
BUY
$83.5 - $98.47 $1,503 - $1,772
18 Added 0.64%
2,836 $246,000
Q2 2020

Jul 15, 2020
BUY
$80.93 - $91.1 $5,988 - $6,741
74 Added 2.7%
2,818 $246,000
Q1 2020

Apr 15, 2020
BUY
$70.67 - $99.01 $190,809 - $267,327
2,700 Added 6136.36%
2,744 $230,000
Q4 2019

Feb 04, 2020
BUY
$84.35 - $95.37 $3,711 - $4,196
44 New
44 $4,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Pacifica Partners Inc. Portfolio

Follow Pacifica Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacifica Partners Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email